The Effects of Ketogenic Diet on Seizures, Cognitive Functions, and Other Neurological Disorders in Classical Phenotype of Glucose Transporter 1 Deficiency Syndrome

Neuropediatrics

Volumn 46, Issue 5, 2015, Pages 313-320

  Gumus, Hakan ^a   Bayram, Ays̈e Kaçar ^a   Kardas, Fatih ^a   Canpolat, Mehmet ^a   Çaʇlayan, Ahmet Okay ^b   Kumandas, Sefer ^a   Kendirci, Mustafa ^a   Per, Huseyin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

children; cognitive functions; glucose transporter protein 1 deficiency syndrome; ketogenic diet; seizures

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; LACTIC ACID; SLC2A1 PROTEIN, HUMAN;

ABSENCE; ADOLESCENT; ALERTNESS; ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; COGNITION; DYSTONIA; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE TRANSPORTER PROTEIN 1 DEFICIENCY SYNDROME; HUMAN; HYPOGLYCEMIA; INFANT; INTELLIGENCE QUOTIENT; KETOACIDOSIS; KETOGENIC DIET; LUMBAR PUNCTURE; MALE; MICROCEPHALY; MOTIVATION; MYOCLONUS SEIZURE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; SEIZURE; SPASTICITY; TREATMENT DURATION; BLOOD; CEREBROSPINAL FLUID; COMPLICATION; DEFICIENCY; DIET THERAPY; DISORDERS OF CARBOHYDRATE METABOLISM; GENETICS; MISSENSE MUTATION; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; SEIZURES; TREATMENT OUTCOME;

ADOLESCENT; BIOMARKERS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM, INBORN ERRORS; CHILD; CHILD, PRESCHOOL; COGNITION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; KETOGENIC DIET; LACTIC ACID; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUTATION, MISSENSE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; SEIZURES; TREATMENT OUTCOME;

EID: 84942552179     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0035-1558435     Document Type: Article

References (29)

1. Klepper J., Scheffer H., Elsaid M. F., Kamsteeg E. J., Leferink M., Ben-Omran T. Autosomal recessive inheritance of GLUT1 deficiency syndrome. Neuropediatrics: 2009; 40 5 207 210
2. Klepper J., Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain- a review. Eur J Pediatr: 2002; 161 6 295 304
3. De Vivo D. C., Trifiletti R. R., Jacobson R. I., Ronen G. M., Behmand R. A., Harik S. I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med: 1991; 325 10 703 709
4. Tzadok M., Nissenkorn A., Porper K., et al. The many faces of Glut1 deficiency syndrome. J Child Neurol: 2014; 29 3 349 359
5. Alter A. S., Engelstad K., Hinton V. J., et al. Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol: 2015; 30 2 160 169
6. De Giorgis V., Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure: 2013; 22 10 803 811
7. Wang D., Pascual J. M., De Vivo D. Glucose Transporter Type 1 Deficiency Syndrome. In: Pagon R. A., Adam M. P., Ardinger H. H., et al. eds. University of Washington, Seattle: GeneReviews [Internet]; 1993-2014. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1430/
8. Klepper J., Leiendecker B. GLUT1 deficiency syndrome-2007 update. Dev Med Child Neurol: 2007; 49 9 707 716
9. Leen W. G., Klepper J., Verbeek M. M., et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain: 2010; 133 Pt 3 655 670
10. Schneider S. A., Paisan-Ruiz C., Garcia-Gorostiaga I., et al. GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord: 2009; 24 11 1684 1688
11. Veggiotti P., Teutonico F., Alfei E., et al. Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype. Brain Dev: 2010; 32 5 404 408
12. Ramm-Pettersen A., Nakken K. O., Skogseid I. M., et al. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol: 2013; 55 5 440 447
13. Weber Y. G., Kamm C., Suls A., et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology: 2011; 77 10 959 964
14. Wang D., Kranz-Eble P., De Vivo D. C. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum Mutat: 2000; 16 3 224 231
15. Mueckler M., Caruso C., Baldwin S. A., et al. Sequence and structure of a human glucose transporter. Science: 1985; 229 4717 941 945
16. Ito Y., Takahashi S., Kagitani-Shimono K., et al. Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan. Brain Dev: 2014
17. Ramm-Pettersen A., Stabell K. E., Nakken K. O., Selmer K. K. Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study. Epilepsy Behav: 2014; 39 111 115
18. Wechsler D. Wechsler Intelligence Scale for Children. 4th ed. London, UK Pearson Assessment: 2004
19. Thorndike R. L., Hagen E. P., Sattler J. M. The Stanford-Binet Intelligence Scale. 4th ed. Technical Manual. New York, NY Riverside Publishing: 1986
20. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV) Washington, DC American Psychiatric Association: 1994
21. Salvador-Carulla L., Reed G. M., Vaez-Azizi L. M., et al. Intellectual developmental disorders: towards a new name, definition and framework for mental retardation/intellectual disability in ICD-11. World Psychiatry: 2011; 10 3 175 180
22. Leen W. G., Wevers R. A., Kamsteeg E. J., Scheffer H., Verbeek M. M., Willemsen M. A. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol: 2013; 70 11 1440 1444
23. Pong A. W., Geary B. R., Engelstad K. M., Natarajan A., Yang H., De Vivo D. C. Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia: 2012; 53 9 1503 1510
24. Haberlandt E., Karall D., Jud V., et al. Glucose transporter type 1 deficiency syndrome effectively treated with modified Atkins diet. Neuropediatrics: 2014; 45 2 117 119
25. Klepper J., Leiendecker B. Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol: 2013; 28 8 1045 1048
26. Veggiotti P., De Giorgis V. Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome. Curr Treat Options Neurol: 2014; 16 5 291
27. Ito Y., Oguni H., Ito S., Oguni M., Osawa M. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol: 2011; 53 7 658 663
28. Rodríguez-Morató J., Xicota L., Fitó M., Farré M., Dierssen M., de la Torre R. Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases. Molecules: 2015; 20 3 4655 4680
29. Covas M. I., de la Torre K., Farré-Albaladejo M., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med: 2006; 40 4 608 616